Development and validation of a therapy‐independent hepatocellular carcinoma survival prediction score

Development and validation of a therapy‐independent hepatocellular carcinoma survival prediction score

Background & Aims Survival in hepatocellular carcinoma (HCC) is associated with several factors. Our aim was to develop and validate an HCC survival prediction score (HCC‐SPS) based on common clinical parameters and excluding the subsequent therapy received, which would be able to prognosticate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Liver cancer international 2022-06, Vol.3 (2), p.82-89
Hauptverfasser: Tan, Terence J.Y., Shen, Liang, Hajiev, Saur, Mak, Lung‐Yi, Sharma, Rohini, Goh, George B.B., Chang, Pik‐Eu, Yuen, Man‐Fung, Pinato, David J., Tan, Chee‐Kiat
Format: Artikel
Sprache:eng
Schlagworte:
ALBI grade
Blood tests
Cancer therapies
Censuses
Committees
Ethics
Hepatitis
Liver cancer
Liver diseases
Medical prognosis
Patients
prognostication
Review boards
Statistical analysis
Variables
Veins & arteries
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background & Aims Survival in hepatocellular carcinoma (HCC) is associated with several factors. Our aim was to develop and validate an HCC survival prediction score (HCC‐SPS) based on common clinical parameters and excluding the subsequent therapy received, which would be able to prognosticate all patients with HCC at the time of diagnosis. Methods The development cohort comprised 1270 patients with HCC seen in our department since January 1988. Univariate analysis was performed for known HCC prognostic parameters. Parameters with P 
ISSN:2642-3561
2642-3561
DOI:10.1002/lci2.45